chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Caller received the first dose of covid 19 vaccine and tested positive for covid.; Caller received the first dose of covid 19 vaccine and tested positive for covid.; Caller received the first dose of covid 19 vaccine and tested positive for covid.; This is a spontaneous report from a Pfizer-sponsored program. A contactable other health professional (patient) reported that a female (age: 22; unit: not reported) patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of COVID 19 vaccine and tested positive for COVID on an unspecified date. She was under quarantine and wanted to know when and if she should get the second dose. Due date for second dose is 11Jan2021. The patient underwent lab tests and procedures which included Covid-19: positive on an unspecified date. The outcome of event was unknown.  Information on the lot/ batch number has been requested.; Sender's Comments: The association between the event lack of effect (Covid-19 test positive) with BNT162b2 can not be completely excluded.
I was vomiting violently, running a temp of 103 degrees, and having problems breathing. I was dizzy and needed assistance walking. I was taken to the hospital with a rapid heart rate, shortness of breath, dehydration and a fever of 103. I was given intravenous fluids, anti-nausea meds, oxygen and meds for fever.
Inconsolable crying for 3 hours after recieving DTap, HIB, prevnar, IPV.
On August the 31st, 2021, immediately after getting the Pfizer vaccine, I experienced uterine cramping. It was abnormal because I take my birth control pills everyday. This cramping was abnormal. I brushed it off. On September 6th, I began to have abnormal cramping again. I went to the restroom and saw I had brown discharge. I freaked out. The rest of the day there was no discharge. On September 7th, I experienced cramping again. I went to the restroom and had a lot of brown discharge with many small pieces of tissue in it. It looked as if someone had rolled wet toilet tissue in their hands and dipped it in brown chocolate. It scared me. This was very unusual. The rest of the day there was no bleeding. Positive COVID-19 test on September 7, 2021.
CLIENT RECEIVED PNEUMOVAX VACCINE ON 09/15/2009 AND REPORTS EXPERIENCING LOW-GRADE FEVER, REDNESS, ITCHING, TENDERNESS AND SWELLING AT INJECTION SITE.  CLIENT PRESENTED TO HEALTH DEPARTMENT FOR EVALUATION ON 09/19/2009.  REDNESS, SWELLING, AND WARMTH NOTED WHICH COVERED ENTIRE RIGHT DELTOID AREA EXTENDING DOWN TO MIDWAY OF ARM. CLIENT FOLLOWED UP WITH PRIVATE PHYSICIAN AND PRESCRIBED KEFLEX FOR FIVE DAYS AND TO APLLY COLD PACK IN INJECTION.  CLIENT IN ON 09/21/2009 FOR FOLLOW-UP EVALUATION.  MINIMAL SWELLING AND REDNESS NOTED.
On 03/16/2021 I had my second dose and in 06/14/2021 I started to get some symptoms but they would go away and on 06/16/2021 I went to the doctor. I was diagnosed with left iritis I am taking prednisone eye drop every 2 hours while awake and Atropine eye drop twice a day. Today I was diagnose with it on my right eye and the treatment is just the Prednisone eye drop every 2 hours till I see my doctor again.
Started to have arm pain immediately after shot, but fever, chills, sweating, headaches, and diarrhea did not start until shortly after midnight following the shot. Took Tylenol the morning after as they persisted, which helped and most symptoms ceased in the afternoon. Headaches and fatigue have continued.
The student was administered a MMR vaccine (lot number T025927) on 8/9/22 with an expiration date of 7/30/22 at a back to school immunization clinic.
After waiting for 15 minutes, I left the site and seemed fine except for a metal taste which I just assumed was the vaccine.  After about 45 minutes I developed a cough but it didn't last longer than a few minutes. When I arrived home I laid down to sleep and when I woke up at 8pm my face was swollen, my left arm was hard and stiff. My neck was also stiff and swollen on the left side. My breathing was fine, there was no swelling of my lips or tongue. I spoke with the on-call doctor who advised that I take 2 benadryl and ibuprofen for the swelling and headache. I was able to sleep throughout the night without issue. In the morning I still had swelling in all the above mentioned areas but was able to raise my left arm, which I was unable to do the night before. My doctor is prescribing me prednisone to help with the swelling.
Pt recv vax on 11/12/98; on 11/27/98 pt exp pimple like rash in mouth, itching, headache, stomach ache; tx=Benadryl, soda baths
Fever, elevated resting pulse (91) for half an hour, dizziness (hour and a half), fatigue
Fever of 104.8 F. Was managed with fever reducers and baths. Fever would return when only using ibuprofen, needed to alternate Tylenol and Ibuprofen in order to manage.
had reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (had reactions) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (had reactions). At the time of the report, VACCINATION COMPLICATION (had reactions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported by the reporter.  Treatment information was not provided by the reporter.
Complained of left arm redness, heat at site, inflammation, 1/4" elevation approximately 3"x3". Instructed to use cold compresses 24 hours then heat 24-48 hours and Benadryl PO as directed. 24 hours, call PCP if no improvement.
Persistent itchy rash starting day 2 after vaccine #1 For txment: PCP gave benadryl vitals taken allergy review recommend - Evaluated 1/13/21  Recommended OK for 2nd vaccine 2nd vaccine 1/14/21 -completed 30 min observation 3 adverse reaction
Information has been received from a health professional concerning a white 25 year old female ophthalmic technician who was vaccinated with a second dose of Hepatitis B vaccine. Subsequently, the patient experienced nausea, vomiting, diarrhea, "possible" fever, and injection site pain and redness of the right arm. The patient told the health care professional "she was not sure if she picked up a flu, or if this was in response to the vaccination." Unspecified medical attention was sought. Upon follow-up the patient received from the health professional, the 2nd dose of hepatitis B vaccine was administered "midday" on 04/21/00 in the right deltoid. Later in the afternoon on 04/21/00, the patient experienced headache in addition to nausea, vomiting, diarrhea, "possible" fever, and injection site pain and redness of the right arm. The reporter indicated that the patient's experiences resolved on approximately 04/23/00. No additional information is expected.
Employee received Flu Vaccine on Monday 10-13-08 at approximately 2:00PM.  Employee reports that about 5:00PM she felt as though she were coming down with a fever (not documented).  She reports experiencing sharp pains in her lower legs and thighs. That same evening, employee reports she experienced a terrible headache, and had a low-grade temp. 99.4.  The following morning, 10-14-08, employee states that she experienced a burning sore throat, and mild-to moderate swelling of her mouth, roof of mouth  and underneath her tongue.  She also reports her face was itching. She took Benadryl and Ibuprophen Saw family physician who ordered her a Solu-Medrol Z Pack.  Now employee reports that on Sunday October 19, her Left eye is swollenher face is itching
Myalgia, Fever, chills Narrative: Per supervisor report: "received 2nd COVID injection on 3/25/2021. C/O fever, body aches, chills.[3/26]"
Asthma exacerbation, upper extremity pain. Tx: Albuterol dosed 2 puff every 4 hrs as needed.
Patient stated having stabbing headache pain and feeling weak at 11pm the same evening after receiving the vaccine.  She stated at around 7am the following morning she felt lethargic, nauseous, increased urination, and chest pain and she went to the ER.
Redness & swelling & itching in Right arm at point of shot. Swelling & itching on Right side of face, mild tingling in teeth.
The pt complained of "popping" sensation in the throat and chest about 1 hour post vax, the pt experienced wheezing, breathing difficulty and feet and hands were swollen 3 times their normal size. The pt also complained of hives that started at the ankles and then became generalized. He was taken to the ER and treated with steroids and Benadryl.
Woke up early morning with terrible cold. Could not control it with any number of covers. Then later when try to get out of bed, I could not , not even get to the bathroom, Had to urinate right on bed. When finally with much effort got seated on bed, my legs we trembling and could not get up. Could not mark numbers on cell because I was trembling al over. Finally was able to phone my neiborhg who took care of me for the next days. Even today after 11 days my knees are weak
day of shot arm hot & sore all day;evening of day p/shot n/v/d, hypersensitivity of skin, severe abd pain, back pain, extreme fatigue, fever, muscle pain & weakness;loss of noc vision, weight, appetite;
FATIGUE, 2 CM LUMP AND TENDERNESS NOTICED 2 DAYS AFTER INJECTION.
Information has been received from a physician concerning a patient who was vaccinated with PNEUMOVAX vaccine (dose and route not reported). On approximately 14-OCT-2008, "in the past 1 to 2 weeks" the patient developed localized redness at the injection site that involved and extensive area of the arm. The patient's symptoms did not begin until a couple days after vaccination. This is one of several reports received from the same source. Additional information has been requested.
did not report any adverse events or issues; received an expired dose of GARD ASIL 9; This spontaneous report as received from a vaccine administrator referring to a 25-year-old female patient. The patients' pertinent medical history, concurrent conditions, concomitant medications, drug reactions and allergies were not reported.    On 12-FEB-2021 at approximately 16:00, the patient was vaccinated with expired dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (lot # R005341, expiration date reported as 31-DEC-2020 (conflicting, also reported as 31-DEC-2021), however upon internal validation established as 06-DEC-2020 and formulation vial; strength, dose and route were not reported) in the right arm accidentally for prophylaxis (expired product administered). It was also reported that HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) did not experience any temperature excursion. The patient left the facility and did not complain of any adverse events or any issues (no adverse event). The reporter stated that the patient was scheduled to receive a COVID vaccination on 13-FEB-2021.
Dr. reported that his 12 yr old son was given a booster dose of Measles virus vaccine, live on 8-JUN-90 he experienced Arthus reaction consisting of synovitis of lt hip, inability to walk and pain at injection site.  ESR was normal.
CHEST PAIN; JOINTS FLARING UP; JOINTS SWELLING; FELT ACHES/PAINS; FLU LIKE SYMPTOMS; This spontaneous report received from a patient via a company representative concerned a male of unspecified age.  The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 30-NOV-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 30-NOV-2021, the patient experienced felt aches/pains, and flu like symptoms. On an unspecified date, the patient experienced chest pain, joints flaring up, and joints swelling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the felt aches/pains, flu like symptoms, chest pain, joints flaring up and joints swelling was not reported. This report was non-serious.
No additional AE reported; Caller is a HCP reporting an AE for VARlVAX. Caller states the vaccine was administered after a temperature excursion; Information has been received from a other health professional, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 28-JAN-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # T012551, expiration date on 10-APR-2022, 0.5 milliliter (anatomical location and administration route were not reported) for prophylaxis. No adverse effects were reported.  The vaccine had a temperature excursion of -13.8 Celsius degrees (C), during 41 minutes. It was confirmed that no previous temperature excursions occurred and a digital data logger was involved.
My tongue tingled and burned after vaccine.  Was recommended to take Benadryl.  Also, the next day, noticed white vertical lines on tip of tongue that swelled.   Went back to pharmacist.   He saw swollen vertical lines on tongue.  Emailed pics to doctor office. They called in steroids.  Then, on 9/28/2021, throat started feeling weird like swollen and thought neck may be too so went back to pharmacist and an Urgent Care. Urgent care gave me a steroid injection as well.  They suggested follow up with primary doctor.
herpes zoster; postherpetic neuralgia; Ramsey Hunt Syndrome; trigeminal neuralgia; Information has been received from a lawyer regarding a case in litigation which referred to a patient (pt) of unknown gender and age. Information regarding concomitant medications, concurrent conditions or medical history was not provided. On an unknown date, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) for its intended purpose: the prevention of shingles (herpes zoster) (exact dose, dose number, route of administration, anatomical site of vaccination, lot number and expiration date were not provided). Afterwards, on an unknown date (reported as after receiving zoster vaccine live (ZOSTAVAX) vaccine), the pt suffered herpes zoster, postherpetic neuralgia, Ramsey Hunt Syndrome (herpes zoster oticus) and trigeminal neuralgia. As a result of those symptoms, the pt was seen and treated by medical providers and was still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, the pt's symptoms had resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of pt's condition. In addition, the pt sustained severe and permanent personal injuries. Further, the pt had suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. Finally, as direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was considered as not recovered. The causal relationship between the events and zoster vaccine live (ZOSTAVAX) was assessed as related.  Herpes zoster, postherpetic neuralgia, trigeminal neuralgia, and herpes zoster oticus were considered as disabling events by the reporter.   Upon internal review, the event of herpes zoster oticus was determined to be medically significant.
Rash; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 20Mar2021 at 02:45 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, asthma and allergy. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced rash. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event rash was unknown.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a nurse, via company representative, refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route and lot number were not reported) for prevention of shingles. Concomitant medications were not reported. On an unknown date the patient experienced red circles and areas, and swelling around injection site. Nurse stated that the patient was prescribed Claritine. The outcome of swelling red circles and areas, and swelling around injection site was unknown. The relationship between the ZOSTAVAX and the events was not reported. This case is linked to case 1309USA013052 via same reporter link. Additional information has been requested.
SHE COMPLAINED SHE COULDN'T WALK OUT BECAUSE OF LETHARGY. SHE WAS WAITED FOR 20 MINUTES   AFTER SECOND DOSE  MODERNA COVID 19. AFTER THEN WE CALLED 911 , EMC TOOK HER TO THE HOSPITAL. SHE DOESN'T HAVE ANY ALLERGY AND BREATHING PROBLEM. HER BLOOD PRESSURE IS NORMAL RANGE
Pt presented with mother to the Urgent Care complaining of intermittent mid sternal chest pain. No fever or chills. No cough. No shortness of breath. He had been vaccinated with 2nd Pfizer dose for Covid on Thursday. SX started 2 days ago. He had taken ibuprofen 2 tablets this am and was no longer having chest pain during the encounter. EKG was performed which showed mild ST elevation in the inferior lateral leads. He was sent to the lab at a healthcare facility for a Troponin which was elevated at 377. He was redirected back to the ER.
First dose given on 04/03/2018: pt suffered from sore arm for 3 days after shot and soreness disappeared. Second dose give on 07/19/2018: patch of red skin around injection site, 3x2 in. in size, itchiness above and below red spots, when away after 1 week. On 07/31/2018, itchy raised spots appeared on ankle and one of fingers.
Pt was administered Engerix-B pediatric dose instead of the Engerix-B adult dose.  Once the nurse realized the error, she informed the patient's physician and informed patient. Pt did not experience an adverse reaction to pediatric dose. Pt was given option to repeat first dose with correct Engerix-B adult dose. Pt chose to restart series and was given first adult dose on 02/03/2023.
Patient arrives from outside facility after having been evaluated in the emergency department due to strokelike syndrome. TIA. Due to resolving symptoms TPA was held at the outside facility and patient is now greater than 5 hours from last known well. ED visit within 6 weeks of receiving the COVID vaccine.
Numbness of my hand with tingling fingers for 3 days accompanied with severe headaches that started from the back of my head to my neck.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021 at 5:33 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Nov-2021 at 5:33 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  The vaccine was stored in an ultra cold freezer at minus 82 degrees Farenheight.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-402935 (Patient Link).
Chills, Fever, aches and pains all over, Injection site pain, Pain the left breast.
whole left arm pain/left arm injection site pain; injection site sensation of warmth; sensitivity to touch; extreme body pain; extreme fatigue; flu-like symptoms; shivering; lack of appetite; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 55-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th February 2020, the patient received the 1st dose of Shingrix (intramuscular). In February 2020, less than an hour after receiving Shingrix, the patient experienced pain in arm, injection site warmth, touch sensitivity increased, general body pain, fatigue, influenza-like symptoms, shivering and appetite absent. The patient was treated with ibuprofen (Advil) and paracetamol (Tylenol). On an unknown date, the outcome of the pain in arm, injection site warmth, touch sensitivity increased, general body pain, fatigue, influenza-like symptoms, shivering and appetite absent were unknown.   It was unknown if the reporter considered the pain in arm, injection site warmth, touch sensitivity increased, general body pain, fatigue, influenza-like symptoms, shivering and appetite absent to be related to Shingrix.  Additional details were provided as follows: After receiving Shingrix, the patient experienced left arm injection site pain with injection site sensation of warmth with sensitivity to touch.  Then within 6 hours, the patient started to experience whole left arm pain with extreme body pain, with extreme fatigue with flu-like symptoms which included shivering.  The patient also reported he had lack of appetite. The reporter was consented to follow up. This case was linked with case US2020028078, reported by the same reporter.
Fever, chills, fatigue. Soreness, swelling and heat at injection site.
This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. The patient's relevant medical history, concomitant medication and past drug history was unknown. On 30-JUN-2015 (reported as "on either 30-JUN-2015 or 01-JUL-2015"), the patient was administered VARIVAX (Merck), 1 vaccine, lot # L002214, expiration date 21-JAN-2017 (dose, frequency and route of administration were not provided), after it had a temperature excursion. That was unknown if there was any relevant laboratory data. At the time of reporting, it was unknown if the patient would ever get VARIVAX (Merck) again and the outcome of VARIVAX (Merck) being given after an excursion was unknown. This is one of several reports received form the same reporter. Additional information has been requested.